Stock Events

Stock Events

Atrium Therapeutics (RNA) Q1 2026 Earnings

Feb 17Confirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-1.27

-1.05

-0.83

-0.61

Details

Expected EPS

N/A

Actual EPS

-0.61

Surprise EPS

N/A

Surprise Percent

N/A

Description

⁨Atrium Therapeutics⁩ (⁦RNA⁩) has reported earnings of ⁦-0.61⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.